Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Coeptis Therapeutics Holdings Inc COEP

Healthcare Biotechnology
Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, including Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc. and Coeptis Pharmaceuticals, LLC., is a biopharmaceutical company. The Company owns, acquires, and develops cell therapy technologies for cancer and other diseases. Its product portfolio and rights are highlighted by assets licensed from Deverra Therapeutics... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:COEP)

Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development

PR Newswire November 7, 2024

Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency Use

PR Newswire October 24, 2024

Coeptis Therapeutics' Chief Scientific and Medical Officer to Present at Upcoming Fall Conferences, Highlighting Progress in Universal Cell Therapy

PR Newswire October 15, 2024

Coeptis Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing

PR Newswire September 19, 2024

Coeptis Therapeutics Chief Executive Officer, Dave Mehalick, Updates and Outlines Strategic Vision in Letter to Shareholders

PR Newswire September 5, 2024

Coeptis Therapeutics Closes on $4.3 Million of Series A Preferred Offering

PR Newswire June 20, 2024

Coeptis Therapeutics' Dr. Colleen Delaney to Present at Allogeneic Cell Therapies Summit 6th Annual Meeting

PR Newswire May 30, 2024

Coeptis Therapeutics to Present its Universal Allogeneic SNAP-CAR NK Cell Therapy at the ISCT 2024

PR Newswire May 8, 2024

Coeptis Therapeutics Announces Poster Data Presentation at American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting

PR Newswire May 2, 2024
View More News ››

Opinion & Analysis (NDAQ:COEP)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:COEP)

$COEP Coeptis News out! #Nasdaq Coeptis Therapeutics

$COEP Coeptis News out! #Nasdaq Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for...
MasterJedijazz - November 7, 2024

$COEP Stocks surging today. Coeptis Therapeutics

$COEP Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency Use https://finance...
MasterJedijazz - November 6, 2024

$COEP Coeptis Therapeutics (Nasdaq: COEP) Expands License

$COEP Coeptis Therapeutics (Nasdaq: COEP) Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency Use...
MasterJedijazz - November 3, 2024

Coeptis Therapeutics Congratulates Alexander Deiters, Profes

News; $COEP Coeptis Therapeutics Congratulates Alexander Deiters, Professor at the University of Pittsburgh, on Receiving the 2024...
whytestocks - April 2, 2024

Coeptis Therapeutics Adds Autoimmune Indications to Exclusiv

Just In: $COEP Coeptis Therapeutics Adds Autoimmune Indications to Exclusive License Agreement with University of Pittsburgh for SNAP...
whytestocks - February 26, 2024

Expected earnings - Coeptis Therapeutics Holdings Inc.

Just In: $COEP Expected earnings - Coeptis Therapeutics Holdings Inc.Coeptis Therapeutics Holdings Inc. (COEP) is expected to report for...
whytestocks - February 8, 2024
View more Bullboard ››

Nurcapital Corp Ltd

Nurcapital Corp Ltd

Nurcapital Corporation Ltd. is a Canada-based capital pool company. The Company is engaged in identifying and evaluating ...
View More »